Joon H. Uhm, M.D.

Closed for Enrollment

• A Pilot Study of APG-157 with Bevacizumab for Patients with Recurrent High-Grade Glioma Rochester, Minn.

  The purpose of this study is to assess the toxicity and effectiveness of bevacizumab with APG-157 for recurrent high grade glioma patients with disease progression after bevacizumab.